BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38038191)

  • 1. Resting Heart Rate: A Valuable Marker for Preventing Kidney Disease.
    Abdin A; Böhm M
    J Am Heart Assoc; 2023 Dec; 12(23):e032580. PubMed ID: 38038191
    [No Abstract]   [Full Text] [Related]  

  • 2. Resting Heart Rate Independent of Cardiovascular Disease Risk Factors Is Associated With End-Stage Renal Disease: A Cohort Study Based on 476 347 Adults.
    Tsai MK; Gao W; Chien KL; Kyaw TW; Baw CK; Hsu CC; Wen CP
    J Am Heart Assoc; 2023 Dec; 12(23):e030559. PubMed ID: 38038184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease.
    Rodriguez-Iturbe B; Correa-Rotter R
    Expert Opin Pharmacother; 2010 Nov; 11(16):2687-98. PubMed ID: 20426701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber MA; Franklin S; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T;
    Ann Intern Med; 2006 Feb; 144(3):172-80. PubMed ID: 16461961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resting heart rate: how to use it for cardiovascular prevention?].
    Fassbind M; Yerly P; Nanchen D
    Rev Med Suisse; 2016 Mar; 12(508):454, 456-9. PubMed ID: 27089603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease.
    Beddhu S; Nigwekar SU; Ma X; Greene T
    Nephrol Dial Transplant; 2009 Aug; 24(8):2482-8. PubMed ID: 19307229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The resting heart rate].
    Bemelmans RH; Visseren FL
    Ned Tijdschr Geneeskd; 2014; 158():A6931. PubMed ID: 24666528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.
    Böhm M; Reil JC; Deedwania P; Kim JB; Borer JS
    Am J Med; 2015 Mar; 128(3):219-28. PubMed ID: 25447617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Changes in Resting Heart Rate, Left Ventricular Dysfunction, Heart Failure and Cardiovascular Disease: CARDIA Study.
    Nwabuo CC; Appiah D; Moreira HT; Vasconcellos HD; Aghaji QN; Ambale-Venkatesh B; Rana JS; Allen NB; Lloyd-Jones DM; Schreiner PJ; Gidding SS; Lima JAC
    Am J Med; 2020 Aug; 133(8):946-953. PubMed ID: 32001229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information?
    Leistner DM; Klotsche J; Palm S; Pieper L; Stalla GK; Lehnert H; Silber S; März W; Wittchen HU; Zeiher AM;
    Eur J Prev Cardiol; 2012 Apr; 19(2):275-84. PubMed ID: 21450610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is chronic kidney disease keeping the heart up all night?
    Shen JI; Norris KC
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):88-90. PubMed ID: 30597755
    [No Abstract]   [Full Text] [Related]  

  • 12. Heart rate: a global target for cardiovascular disease and therapy along the cardiovascular disease continuum.
    Custodis F; Reil JC; Laufs U; Böhm M
    J Cardiol; 2013 Sep; 62(3):183-7. PubMed ID: 23806547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Background of measures against chronic kidney disease].
    Hishida A
    Nihon Rinsho; 2008 Sep; 66(9):1639-44. PubMed ID: 18788388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic kidney disease. Better detect, slow its progression and cardiovascular risk, prepare for renal replacement therapy].
    Legendre C
    Rev Prat; 2012 Jan; 62(1):27-9. PubMed ID: 22335062
    [No Abstract]   [Full Text] [Related]  

  • 15. Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.
    Inoue T; Iseki K; Iseki C; Ohya Y; Kinjo K; Takishita S
    Clin Exp Nephrol; 2009 Oct; 13(5):487-493. PubMed ID: 19444548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifying effects of resting heart rate on the association of binge drinking with all-cause and cardiovascular mortality in older Korean men: the Kangwha Cohort Study.
    Ryu M; Gombojav B; Nam CM; Lee Y; Han K
    J Epidemiol; 2014; 24(4):274-80. PubMed ID: 24705645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in patients with chronic kidney disease: why, who and when?
    Gluba A; Rysz J; Banach M
    Expert Opin Pharmacother; 2010 Nov; 11(16):2665-74. PubMed ID: 20977401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Do the effects of blood pressure drugs differ by kidney function?
    Ann Intern Med; 2006 Feb; 144(3):I33. PubMed ID: 16461958
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between resting heart rate just before starting the first dialysis session and mortality: A multicentre prospective cohort study.
    Inaguma D; Koide S; Takahashi K; Hayashi H; Hasegawa M; Yuzawa Y;
    Nephrology (Carlton); 2018 May; 23(5):461-468. PubMed ID: 28332737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.